Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 6, Issue 11 (2017)

Hemato biochemical alterations and therapeutic management of babesiosis in a Pit bull Dog: A case study

Author(s):
Sheikh Tajamul Islam, Waseem Ul Firdos, Amir Amin Sheikh, Mohd Younis Ganaie and Rakshanda Baghat
Abstract:

Canine babesiosis is clinically significant haemoprotozoan infection and is typically characterized by hemolytic anemia, thrombocytopenia, fever, and splenomegaly. An eight month old male Pitbull dog was presented to the Sanjay Gandhi Animal Care Centre Rajouri garden, New Delhi, India with a history of decreased feed intake, dullness, and lethargy since one week. Clinical examination revealed pyrexia (105.7°F), tachypnea, and pale mucous membrane. Haematology revealed anaemia (Hb- 8.11 g/dl), thrombocytopenia (Platelet count- 105 thou/mm3) and neutrophilia (77 %), B. gibsoni (+++) was evidenced in blood smear. Treatment was initiated with Metronidazole @ 15mg/kg IV, Ringer lactate 150 ml IV, Rantidine (Ranloc) 0.7 ml IM, Meloxicam (Melonex) 0.6 ml IV on the day of presentation to hospital, followed with prescribed combination therapy of Doxycycline @ 5 mg/kg PO q 12h, Metronidazole @ 15 mg/kg PO q 12h, Clindamycin @ 25 mg/kg PO q 12h for 10 days and Eupotorium Q 200 3 drops TID PO. There were no adverse reactions and the dog showed clinical and haematological improvement from day 5 of the treatment and recovered completely by the end of therapeutic protocol.
Pages: 632-634  |  513 Views  10 Downloads
How to cite this article:
Sheikh Tajamul Islam, Waseem Ul Firdos, Amir Amin Sheikh, Mohd Younis Ganaie, Rakshanda Baghat. Hemato biochemical alterations and therapeutic management of babesiosis in a Pit bull Dog: A case study. Pharma Innovation 2017;6(11):632-634.
The Pharma Innovation Journal